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Summary 4,21-Dehydrogeissoschizine (5)  was proven to THE reaction sequence leading from tryptamine (1) and 
be a metabolic intermediate in the enzymatic synthesis secologanin (2) to heteroyohimbine alkaloids has largely 
of cathenamine (6) and its transformation products been elucidated using cell-free systems from Catharanthus 
ajmalicine (7), 19-epiajmalicine (8), and tetrahydro- yoseus.l-s Besides strictosidine (3), a further intermediate 
alstonine (9) ; the enzyme catalysing the synthesis of in this pathway, cathenamine (6) (20,2l-didehydroajmali- 
(6) from (5)  was identified and named cathenamine cine; has been discovered.4 Furthermore Guettarda eximia 
synthase. (Rubiaceae) proved to be a rich source for this natural 
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intermediate.5 From the same plant material a second 
compound was isolated and its structure identified as 
4,2 1-dehydrogeissos~hizine~(5). Chemical transformationss 
of this compound lead to either cathenamine (6) or geisso- 
schizine (10). These biomimetic reactions reflect closely 
the postulated biosynthetic expectations of an inter- 
mediate located between 4,2 1-dehydrocorynantheine alde- 
hyde (4) and cathenamine (6). 4,2 1-Dehydrogeissoschizine 
(5) was therefore tested as a substrate for heteroyohimbine 
alkaloid formation using enzyme preparations from C. 
Yoseus cell cultures in the presence of NADPH.' Under 
these conditions [0.2pmol of (5), 1.0pmol NADPH, 50 
pmol KP042- buffer, pH 7.0, 1 mg protein, total vol. 0.6 
ml, 30 O C ,  120 min] transformation of this substrate (5) to 
(7) (25%), (8) (18%), and (9) (11%) was achieved. The 
products were analysed by quantitative t.1.c. followed by 
mass spectroscopy (each compound: m/e 352 M+) as well as 
radioimmunoassay.8 Omission of NADPH led to the 
formation of (6) in 74% yield. Cathenamine (6) was 
identified by mass spectroscopy (350 Mf) and quantified 
by conversion5 into (9) using BH,- and subsequent radio- 
immunological determination.8 Employing this assay sys- 
tem the conversion of (5) into (6) was further characterized. 
The reaction proceeded linearly with time, and was affected 
by pH (maximal conversion at  pH 6-6)) and protein (satur- 
ation at  3 mgml-1) and substrate concentration (K,  0.6 
mM). In the absence of enzyme no conversion of (5) into 
(6) occurred even after prolonged incubation up to 24 h. 
In order to establish (5) as an obligatory intermediate in 
the biosynthetic sequence leading to the heteroyohimbine 
alkaloids, [1-14C]-(1) and (2) were allowed to be transformed 
in the presence of a tenfold [with respect to ( l ) ]  excess of 
unlabelled (5), enzyme, and NADPH. The specific activity 
of the alkaloids (7), (€9, and (9) formed was ten times less 
than that of the control experiment which was performed in 
the absence of (5). This proves that (1) is channelled 
through (5) in the course of the formation of (7), (8),  and 
(9). Furthermore, short-term incubations of [ l-WC]-(l) 
and (2) in the presence of (5), led to the accumulation of 
radioactivity in (5). Reduction of labelled (5), in the presence 
of a carrier, by BH4- gave radioactive isositsirikine (lla) 
and its C-16 isomer (llb).6 This experiment proves that 
the suspected intermediate is formed under cell-free con- 
ditions from distant precursors and establishes (5)  as an 
obligatory intermediate in the formation of the heteroyo- 
himbine alkaloids (7), (8), and (9). The new enzyme 
described here, which catalyses the formation of (6) from 
(5), is named cathenamine synthase. 
Under NADPH regenerating conditions [isocitrate de- 
hydrogenase system] (5) is transformed by C. roseus 
extracts in cu. 10% yield into geissoschizine (10) which is 
known not to be a direct precursor of (7) and its isomers2 
(8) and (9).  
If the sequence of reactions from (1) and (2) to the hetero- 
yohimbine derivatives (7), (8), and (9) is allowed to proceed 
in the presence of D20 a total of two deuterium atoms is 
incorporated, one on to each of C-18 and C-20, respectively.9 
In contrast, if (5) is used as substrate for the NADPH- 
dependent reaction only one deuterium atom is incorporated 
into (7), (8), and (9). This result indicated that under these 
conditions no isomerisation takes place when (5) is reached 
which would lead to (4) or its 20, 21-isomer. Furthermore, 
the incorporation of only one deuterium atom during the 
conversion of (5) into (7). (8). and (9) sutmorts the finding 
that (5) is the immediate precursor of (6) in the biosyn- 
thetic pathway as outlined in the Scheme. 
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We consider (5) to occupy a crucial position a t  the branch 
point in the biosynthesis of Ibogu, Aspidosperma, and 
Corvnanthe tvDe alkaloids. 
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